Affinity Asset Advisors’s ADC Therapeutics ADCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-474,744
| Closed | -$1.5M | – | 78 |
|
|
2024
Q2 | $1.5M | Buy |
+474,744
| New | +$1.5M | 0.17% | 66 |
|
|
2024
Q1 | – | Sell |
-1,013,540
| Closed | -$1.68M | – | 78 |
|
|
2023
Q4 | $1.68M | Sell |
1,013,540
-86,460
| -8% | -$144K | 0.31% | 51 |
|
|
2023
Q3 | $987K | Buy |
1,100,000
+500,000
| +83% | +$449K | 0.28% | 50 |
|
|
2023
Q2 | $1.29M | Hold |
600,000
| – | – | 0.45% | 38 |
|
|
2023
Q1 | $1.17M | Buy |
+600,000
| New | +$1.17M | 0.39% | 46 |
|